Drug General Information (ID: DDIPVNSJXE)
  Drug Name Cyclophosphamide Drug Info Azathioprine Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antineoplastics Immunosuppressive Agents
  Structure

 Mechanism of Cyclophosphamide-Azathioprine Interaction (Severity Level: Moderate)
     Additive myelosuppressive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Cyclophosphamide Azathioprine
      Mechanism 1 Myelosuppressive effects Myelosuppressive effects
      Key Mechanism Factor 1
Factor Name Myelosuppressive effects
Factor Description Myelosuppression, also known as bone marrow suppression, is a decrease in bone marrow activity that leads to a decrease in the production of blood cells. Some blood cell disorders include: erythrocytopenia (anemia), leukopenia (neutropenia), and thrombocytopenia (thrombocytopenia).
      Mechanism Description
  • Additive myelosuppressive effects by the combination of Cyclophosphamide and Azathioprine 
     Increased risk of hepatotoxicity Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Cyclophosphamide Azathioprine
      Mechanism 2 Hepatotoxicity Hepatotoxicity
      Key Mechanism Factor 2
Factor Name Hepatotoxicity
Factor Description Combination of drugs that can induce hepatotoxicity may increase the risk of liver injury. Symptoms vary depending on the level of exposure and the total extent of liver damage, and may cause few symptoms if the damage is mild, and eventually lead to liver failure in patients with severe damage.
      Mechanism Description
  • Increased risk of hepatotoxicity by the combination of Cyclophosphamide and Azathioprine 

Recommended Action
      Management If concomitant therapy is needed patients should be monitored for signs and symptoms of hepatotoxicity and myelotoxicity. Patients should be advised to promptly notify their physician if they experience fever, chills, sore throat, mouth sores, unusual fatigue, bleeding, bruising, abdominal pain, darkened urine, or pale stools.

References
1 Shaunak S, Munro JM, Weinbren K, Walport MJ, Cox TM "Cyclophosphamide-induced liver necrosis: a possible interaction with azathioprine." Q J Med 67 (1988): 309-17. [PMID: 3060893]